JME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Molecular Endocrinology (2009) 42 185-190    DOI: 10.1677/JME-08-0150
© 2009 Society for Endocrinology

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
JME-08-0150v1
42/3/185    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seppänen-Laakso, T.
Right arrow Articles by Oresic, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seppänen-Laakso, T.
Right arrow Articles by Oresic, M.

Review

How to study lipidomes

Tuulikki Seppänen-Laakso and Matej Oresic

VTT Technical Research Centre of Finland, PO Box 1000 (Tietotie 2), Espoo FI-02044 VTT, Finland

(Correspondence should be addressed to M Oresic Email: matej.oresic{at}vtt.fi)


    Abstract
 Top
 Abstract
 Introduction
 Methods for lipidomics
 Applications of lipidomics
 Concluding remarks
 Declaration of interest
 Funding
 References
 
Lipidome is loosely defined as the entire spectrum of lipids in a biological system. Given the modern lipidomics platforms for the first time empower us with the ability to obtain a snapshot of complete cellular/organismal lipidome, many surprises and discoveries are likely awaiting us in the area of lipids as related to cellular/organismal physiology. The lipidomics approaches can be applied both as the phenotyping platform and for the hypothesis-driven research aiming to elucidate, e.g., a specific pathway or gene function. Modern lipidomics methods combine the latest mass spectrometry technology and bioinformatics methods with traditional methods such as for sample preparation and lipid extraction.


    Introduction
 Top
 Abstract
 Introduction
 Methods for lipidomics
 Applications of lipidomics
 Concluding remarks
 Declaration of interest
 Funding
 References
 
The ‘omics’ revolution has stimulated the concept of molecular profiling in biological systems. Although having been an intensive area of research already in the 1960s, lipid research has recently gained prominence with the emergence of lipidomics (Han & Gross 2005, Oresic et al. 2008). Chemically, lipids are broadly defined as hydrophobic or amphiphilic small molecules that originate either entirely or in part from two distinct types of building blocks: ketoacyl and isoprene groups (Fahy et al. 2005). Structural diversity of lipid building blocks and many ways they can be combined lead to a vast number of possible molecular lipids in a given biological system. We estimated that this number is of the order of 200 000 (Yetukuri et al. 2008). This clearly demands specific solutions for lipidomic analysis, handling of lipidomics data, both at the level of data processing and lipid identification, as well as for the lipid pathway analysis (Yetukuri et al. 2007).

Recent advances in analytical techniques for metabolomics (Goodacre et al. 2004, Van der Greef et al. 2004) have empowered us with better tools for global characterization of lipids at the molecular level. Modern approaches for lipidomic analysis are dominated by mass spectrometry (MS; Want et al. 2005), commonly preceded by separation by liquid chromatography (LC; Sommer et al. 2006) or gas chromatography (GC; Jiye et al. 2005). The novel MS-based lipidomics methods afford the study of intact lipid molecular species from very small amounts of samples (Han & Gross 2005, Schwudke et al. 2006), e.g. from cells or tissue biopsies. Such methods, due to their wide dynamic range, enable quantitative or relative determination of compounds across a broad range of concentrations. Albeit still being far from complete coverage of lipids in biological systems, the progress of lipidomics affords increasing penetrance into global lipidomes as well as their characterization in physiological context.


    Methods for lipidomics
 Top
 Abstract
 Introduction
 Methods for lipidomics
 Applications of lipidomics
 Concluding remarks
 Declaration of interest
 Funding
 References
 
This section provides an overview of different stages of a typical lipidomics platform, from sample preparation to bioinformatics. For in-depth discussions and specific methods, the reader is advised to refer to the recently published series of books on the topic (Brown 2007a,b,c).

Samples

The samples should be stored frozen at –80 °C or lower, multiple melting of the samples should be avoided and the samples should be handled in cold (e.g. at –20 °C) during the preparation to avoid lipid degradation mostly due to oxidation of polyunsaturated fatty acids. Cultured or isolated cells from animal or microbial sources are usually suspended in buffer solutions and determining the protein content of such a sample enables also quantification of lipids. After taking an aliquot for protein measurement, the rest of the sample can be spiked with internal standards and used to extract lipids. Proteins are precipitated simultaneously when using chloroform:methanol mixtures or, for example acetonitrile for lipid extraction. To break the cells, homogenization with glass beads is efficient. Ultrasonic bath has also been applied. However, as a potential drawback, this approach is to some extent equivalent to warming of the sample.

Tissue samples must be first homogenized, and if the fat content within the sample set is variable or if the sample amount is extremely small, determination of total protein concentration and addition of appropriated internal standards are essential steps for quantification. Homogenization on glass beads by using frozen tissues is sufficient for muscle tissue samples, for example. Proteins are precipitated most commonly by methanol during the extraction procedure with chloroform:methanol.

In a clinical setting, a serum is the most common sample type when studying lipids. Serum is normally first spiked with internal standards and due to the high albumin content, precipitation of proteins is essential. In addition to methanol or isopropanol, acid is sometimes used for removing proteins, but it may hydrolyse some lipids and can thus have an effect on the free fatty acid content. The type of anticoagulant used during blood drawing can affect the amount of lysophospholipids, the use of EDTA is mostly recommended.

Extraction of lipids

The extraction methods developed for the isolation of lipids containing both neutral and polar constituents at the end of the 1950s (Folch et al. 1957, Bligh & Dyer 1959) are still widely used, mostly in modified forms. The technique is based on a mixture of chloroform and methanol (2:1) including washing with salt solution or adjusting the amount of water to improve lipid extraction. To enhance the recovery of phospholipids, the proportion of methanol can be increased (von Thiele 1979, Holland et al. 2003). The extraction method is often highly dependent on the analytical method used. For example, for the determination of fatty acid composition, chloroform:methanol extract is evaporated and the residue is hydrolysed and methylated for GC analysis. On the other hand, avoiding extraction of triacylglycerols by using methanol only is beneficial if the target is to determine free fatty acids and sterols simultaneously with hydrophilic metabolites by using GC MS-based metabolomic profiling. In addition to specific solvent systems, solid phase extraction or chromatographic separation on silica thin-layer plates (Lutzke & Braughler 1990) or a silica column is used to fractionate lipid extracts before more detailed analysis. Targeted analyses of eicosanoids (Masoodi et al. 2008) or sphingolipids (Bodennec et al. 2000), for example, provide special and well-optimized extraction and fractionation systems.

Traditional lipid and fatty acid analyses

Routine kit-based spectrophotometric measurements for total and high-density lipoprotein cholesterol and further calculation of low-density cholesterol levels by Friedewald equation (Friedewald et al. 1972), as well as determining serum triacylglycerol levels are still reasonable and informative methods to describe general lipid balance in the body. Global lipidomics techniques gives data on the level of different lipid subclasses and the sum of cholesterol containing lipid species is not directly linked to the total amount of cholesterol. Correspondingly, the sum of triacylglycerols is not necessarily the same as the spectrophotometric result that indicates the amount of glycerol after hydrolysis of fatty acids. The basic reason for these inconsistencies is the large amount of different overlapping cholesteryl ester and triacylglycerol species. It is known that the length and unsaturation as well as lipid concentrations are affecting instrument responses of phospholipids (Koivusalo et al. 2001) in electrospray ionization-MS (ESI-MS).

GC analysis of fatty acid composition of total serum, phospholipids or cholesteryl esters is still a method of choice in respect of interpreting fatty acid metabolism (Seppänen-Laakso et al. 2002). The determination of fatty acid methyl ester is a highly reproducible and repeatable method and even very small changes may turn out both significant and important. Isomeric forms of fatty acids, like cis and trans, can be analysed by GC when using a proper capillary column. Fatty acids originating from the sn-1 or sn-2 positions in glycerophospholipids can be analysed after the treatment with phospholipases. The analysis of free fatty acids can be performed without derivatization or after trimethylsilylation, for example.

HPLC is a useful method for lipid extracts to separate different classes as groups, such as cholesteryl esters, triacylglycerols, free cholesterol, phosphatidylethanolamines, phosphatidylcholines, sphingomyelins and lysophospholipids (Fig. 1). Normal-phase techniques with evaporative light-scattering detection have proved to be the most successful for class separation (Homan & Anderson 1998, Seppänen-Laakso et al. 2001), although these methods are not usually coupled online with the MS detection. The reversed-phase technique, which enables partial separation of single molecular lipid species is still more routinely used in LC-MS (Yetukuri et al. 2007).


Figure 1
View larger version (29K):
[in this window]
[in a new window]

 
Figure 1 Summary of methods for lipid analysis. (A) Traditionally, serum cholesterol and triacylglycerol levels have been measured. (B) High performance liquid chromatographic separation using normal-phase techniques and evaporative light-scattering detection enables the separation of major lipid classes. (C and D) Isolation of phospholipid fraction (PL) is performed on silica thin-layer chromatography (TLC) and the fatty acid composition of total serum or its PL fraction is determined by capillary gas chromatography (GC). (E) Two-dimensional GC coupled to time-of-flight mass spectrometry (GCxGC-TOF) is used for small molecule metabolomics and (F–G) liquid chromatography-mass spectrometry (LC-MS) is commonly used in lipidomics. (H) Data mining and processing methods are needed to analyse the data.

 
Lipidomic analysis

Global lipidomics means mapping the entire spectrum of lipids and lipid molecular species in a biological system, in lipidome. It can be shotgun lipidomics if the lipid extract is introduced directly into the mass spectrometer (Han & Gross 2005, Schwudke et al. 2006) or LC-MS when the extract is introduced to MS after chromatographic separation (Houjou et al. 2005, Laaksonen et al. 2006). Targeted lipidomics, in turn, aims to quantify a single or multiple related lipids, e.g. from a specific class such as prostaglandins or triacylglycerols. The most common ionization technique in global lipidomics approaches is ESI, which is a soft ionization method that can be combined with several types of mass analysers such as triple quadrupole, ion trap, time-of-flight (TOF) and orbitrap. ESI is most often used in positive ion mode (ESI+) for global approaches, since ESI+ enables coverage of diverse classes such as major phospholipids, sphingolipids and acylglycerols. However, in particular when phospholipids are the focus, some classes such as phosphatidylinositol, phosphatidylserine and phosphatidic acid are not suitable for ESI+ analysis and the negative ion mode (ESI–) is advantageous. Additionally, ESI– analysis can provide information about carboxylate anions of the fatty acids in different phospholipids (Watson 2006).

Quantification of lipid molecular species is usually performed by using internal standards, often as a mixture covering most lipid classes. If available, labelled reference compounds would best correspond to the compounds in lipid mixtures. The quantification procedures including several practical aspects have been discussed recently in detail (Moore et al. 2007).

Identification of compounds in LC-MS can be a time-consuming issue. Self-made libraries based on reference substances are of high importance and should contain also information on MS/MS fragmentation obtained by tandem MS (LC-MS/MS). Precursor ion scanning and neutral loss scanning of polar head groups or fatty acids in phospholipids are widely used in detection and identification (Taguchi et al. 2005).

Following the raw data acquisition from the MS instrument, the data need to be processed to convert the raw signal into a list of lipid molecular concentrations for each sample measured (Katajamaa & Oresic 2007, Yetukuri et al. 2008). The specific data processing steps may vary depending on the instrument and the data acquisition mode. The analysis and interpretation of lipidomics data, following the data processing, typically consist of statistical (e.g. testing for differential expression, multivariate analysis such as clustering) and bioinformatics approaches (e.g. mapping to lipid pathways; Yetukuri et al. 2007, 2008).


    Applications of lipidomics
 Top
 Abstract
 Introduction
 Methods for lipidomics
 Applications of lipidomics
 Concluding remarks
 Declaration of interest
 Funding
 References
 
In this section we briefly overview selected and illustrative applications of lipidomics, aiming to cover multiple strategies for lipidomics as well as multiple research areas and challenges. The lipidomics profiles from cells, tissues or body fluids provide a global snapshot of lipid concentrations in a particular biological sample, corresponding e.g. to a specific physiological state, time or intervention response. Due to untargeted and global nature of lipidomics, new important biological functions of cells and tissues can arise as derived from lipidomics data.

The lipotoxicity hypothesis states that the link between obesity and these metabolic complications may be related to organ-specific toxic effects induced by excess of nutrients in the form of reactive lipid species such as ceramides (Unger 2002). Limited adipose tissue (AT) expandability may be one mechanism leading to excess flux of fatty acids from AT to peripheral tissues, resulting in the synthesis of toxic lipids. In this context, we studied the PPARG(–/–) Lep(ob)/Lep(ob) (POKO mouse), which is characterized by limited AT expandability due to ablation of PPARG and a severe diabetic phenotype (Medina-Gomez et al. 2007). Using UPLC/MS-based global lipidomics approach, we indeed found that the pancreatic islets, skeletal muscle and liver in POKO mouse are characterized by elevated ceramides. These changes were accompanied by depletion of antioxidant phospholipids in islets and a distinct triacylgycerol profile in the liver (Medina-Gomez et al. 2007). Using new lipid pathway reconstruction methodology, we later demonstrated that the synthesis of ceramides in liver is due to increased de novo synthesis as well as activity of the salvage pathway (Yetukuri et al. 2007).

Schmitz et al. (2006) have applied the lipidomics approach with ESI-MS/MS techniques in studying structural and functional defects of ABC-transporters in cellular lipid trafficking. A higher APOA1 specific efflux was observed for monounsaturated PC species together with a decreased contribution of polyunsaturated PC species. Medium-chain sphingomyelin species (SM14:0 and SM16:1) were preferentially translocated to APOA1 in both fibroblasts and macrophages. Combining the analysis of bile acids and phytosterols to lipidomics would further help to understand also the formation of toxic bile.

Breast cancer is the most frequently diagnosed cancer among women, an estimated 200 000 new cases in 2006 in the USA. Lysophospholipids are known activators of proliferation and growth in breast cancer and have been suggested to be potential biomarkers in blood stream (Murph et al. 2007). Methanol extract of plasma contains lysophosphatidic acid (LPA) species that are determined by LC-MS/MS in negative ion mode. Lysophosphatidylcholines (LPCs) are then analysed in positive ion mode after different HPLC run. Already during blood sampling it is important to use EDTA or citrate to chelate calcium ions and decrease the ability of LPA-producing enzymes to actively form LPA during sample processing (Murph et al. 2007).

Quantitative determination of eicosanoids in biological samples is problematic. Practical advices have been given in Wang & DuBois (2007), for example. Masoodi et al. (2008) have been focused purely on LC/ESI-MS/MS-based targeted lipidomics in the analysis of bioactive lipid mediators, leucotrienes, resolvins, protectins and related hydroxy-fatty acids. They have reported the limits of detection and quantification to be 10–20 and 20–50 pg respectively. For prostanoid analysis, the corresponding levels were 0.5–50 and 2–100 pg respectively (Masoodi & Nicolaou 2006).

Autoxidation of cholesterol induced by a free-radical mechanism generates ‘oxycholesterols’, the major ones being 25-hydroxycholesterol and cholestantriol. Several of those components have been demonstrated to be cytotoxic, atherogenic, mutagenic and carcinogenic. An atmospheric pressure chemical ionization LC/MS technique has been used in their quantification (Manini et al. 1998). The level of 7-ketocholesterol in lyophilized beef was about the same as obtained by LC with u.v. detection (27.3 vs 24.7 µg/g), but the advantage of using MS techniques was that two other oxidation products could also be found and quantified.

The oxidation of phospholipids in biological membranes has been implicated in a variety of human diseases, such as atherosclerosis, ischaemia, carcinogenesis and Alzheimer's disease. Plasmalogen phospholipids have a vinyl ether substituent at the sn-1 position of the glycerol backbone and a polyunsaturated fatty acid in sn-2 position, which are susceptible to oxidative reactions that occur at cell membranes. The structure determinations of these oxidation products have been performed both by electron ionization GC/MS and LC-MS/MS (Khaselev & Murphy 2000, Zemski Berry & Murphy 2005). Accurate masses of phosphatidylcholine and LPCs oxidation products in human plasma (Adachi et al. 2006) have been determined by quadrupole TOF MS (Q-TOF).


    Concluding remarks
 Top
 Abstract
 Introduction
 Methods for lipidomics
 Applications of lipidomics
 Concluding remarks
 Declaration of interest
 Funding
 References
 
Lipidomics is a relatively new addition to the ‘omics’ nomenclature. The lipidomics approaches can be applied both as the phenotyping platform, e.g. for biomarker screening and for the hypothesis-driven research aiming to elucidate, e.g. specific pathway or gene function. Given the modern lipidomics platforms for the first time empower us with the ability to obtain a snapshot of complete cellular/organismal lipidome, many surprises and discoveries are likely awaiting us in the area of lipids as related to cellular/organismal physiology.

However, the ‘old school’ lipidology may still be of great value. Since the lipids have been an intense area of research already in the 1960s, the traditional methods in particular for sample preparation and lipid extraction are a valuable resource also for today's lipidomics platforms. Modern lipidomics methods, utilizing the latest MS technology and bioinformatics methods, therefore still require in-depth understanding of traditional lipid biochemistry.


    Declaration of interest
 Top
 Abstract
 Introduction
 Methods for lipidomics
 Applications of lipidomics
 Concluding remarks
 Declaration of interest
 Funding
 References
 
The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.


    Funding
 Top
 Abstract
 Introduction
 Methods for lipidomics
 Applications of lipidomics
 Concluding remarks
 Declaration of interest
 Funding
 References
 
This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.


    References
 Top
 Abstract
 Introduction
 Methods for lipidomics
 Applications of lipidomics
 Concluding remarks
 Declaration of interest
 Funding
 References
 
Adachi J, Asano M, Yoshioka N, Nushida H & Ueno Y 2006 Analysis of phosphatidylcholine oxidation products in human plasma using quadrupole time-of-flight mass spectrometry. Kobe Journal of Medical Sciences 52 127–140.[Medline]

Bligh EG & Dyer WJ 1959 A rapid method of total lipid extraction and purification. Canadian Journal of Biochemistry and Physiology 37 911–917.[Medline]

Bodennec J, Koul O, Aguado I, Brichon G, Zwingelstein G & Portoukalian J 2000 A procedure for fractionation of sphingolipid classes by solid-phase extraction on amnopropyl cartridges. Journal of Lipid Research 41 1524–1530.[Abstract/Free Full Text]

Brown, AH Lipodomics and Bioactive Lipids: Mass Spectrometry Based Lipid Analysis , Methods in Enzymology vol 4322007aSan Diego:Academic Press:

Brown, AH Lipodomics and Bioactive Lipids: Specialized Analytical Methods and Lipids in Disease , Methods in Enzymology vol 4332007bSan Diego:Academic Press:

Brown, AH Lipodomics and Bioactive Lipids: Lipids and Cell Signaling , Methods in Enzymology vol 4342007cSan Diego:Academic Press:

Fahy E, Subramaniam S, Brown HA, Glass CK, Merrill AH Jr, Murphy RC, Raetz CR, Russell DW, Seyama Y, Shaw W et al. 2005 A comprehensive classification system for lipids. Journal of Lipid Research 46 839–862.[Abstract/Free Full Text]

Folch J, Lees M & Sloane Stanley GH 1957 A simple method for the isolation and purification of total lipides from animal tissues. Journal of Biological Chemistry 226 497–509.[Free Full Text]

Friedewald WT, Levy RI & Fredrickson DS 1972 Estimation of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clinical Chemistry 18 499–502.[Abstract]

Goodacre R, Vaidyanathan S, Dinn WB, Harrigan GG & Kell DB 2004 Metabolomics by numbers: acquiring and understanding global metabolite data. Trends in Biotechnology 22 245–252.[CrossRef][Web of Science][Medline]

Van der Greef J, Stroobant P & Van der Heijden R 2004 The role of analytical sciences in medical systems biology. Current Opinion in Chemical Biology 8 559–565.[CrossRef][Web of Science][Medline]

Han X & Gross RW 2005 Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples. Mass Spectrometry Reviews 24 367–412.[CrossRef][Web of Science][Medline]

Holland WL, Stauter EC & Stith Bj 2003 Quantification of phosphatidic acid and lysophosphatidic acid by HPLC with evaporative light-scattering detection. Journal of Lipid Research 44 854–858.[Abstract/Free Full Text]

Homan R & Anderson MK 1998 Rapid separation and quantification of combined neutral and polar lipid classes by high-performance liquid chromatography and evaporative light-scattering mass detection. Journal of Chromatography. B 708 21–25.[CrossRef]

Houjou T, Yamatani K, Imagawa M, Shimizu T & Taguchi R 2005 A shotgun tandem mass spectrometric analysis of phospholipids with normal-phase and/or reverse-phase liquid chromatography/electrospray ionization mass spectrometry. Rapid Communications in Mass Spectrometry 19 654–666.[CrossRef][Web of Science][Medline]

Jiye A, Trygg J, Gullberg J, Johansson AI, Jonsson P, Antti H, Marklund SL & Moritz T 2005 Extraction and GC/MS analysis of the human blood plasma metabolome. Analytical Chemistry 77 8086–8094.[Medline]

Katajamaa M & Oresic M 2007 Data processing for mass spectrometry-based metabolomics. Journal of Chromatography. A 1158 318–328.[CrossRef][Web of Science][Medline]

Khaselev N & Murphy RC 2000 Structural characterization of oxidized phospholipid products derived from arachidonate-containing plasmenyl glycerophosphocholine. Journal of Lipid Research 41 564–572.[Abstract/Free Full Text]

Koivusalo M, Haimi P, Heikinheimo L, Kostiainen R & Somerharju P 2001 Quantitative determination of phospholipid compositions by ESI-MS: effects of acyl chain length, unsaturation, and lipid concentration on instrument response. Journal of Lipid Research 42 663–672.[Abstract/Free Full Text]

Laaksonen R, Katajamaa M, Päivä H, Sysi-Aho M, Saarinen L, Junni P, Lütjohann D, Smet J, Coster RV, Seppänen-Laakso T et al. 2006 A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscle. PLoS ONE 1 e97[CrossRef][Medline]

Lutzke BS & Braughler JM 1990 An improved method for the identification and quantitation of biological lipids by HPLC using laser light-scattering detection. Journal of Lipid Research 11 2127–2130.

Manini P, Andreoli R, Careri M, Elviri L & Musci M 1998 Atmospheric pressure chemical ionization liquid chromatography/mass spectrometry in cholesterol oxide determination and characterization. Rapid Communications in Mass Spectrometry 12 883–889.[CrossRef][Web of Science]

Masoodi M & Nicolaou A 2006 Lipidomic analysis of twenty-seven prostanoids and isoprostanes by liquid chromatography/electrospray tandem mass spectrometry. Rapid Communications in Mass Spectrometry 20 3023–3029.[CrossRef][Web of Science][Medline]

Masoodi M, Mir AA, Petasis NA, Serhan CN & Nicolau A 2008 Simultaneous lipidomic analysis of three families of bioactive lipid mediators leukotrienes, resolvins, protectins and related hydroxy-fatty acids by liquid chromatography/electrospray ionisation tandem mass spectrometry. Rapid Communications in Mass Spectrometry 22 75–83.[CrossRef][Web of Science][Medline]

Medina-Gomez G, Gray SL, Yetukuri L, Shimomura K, Virtue S, Campbell M, Curtis RK, Jimenez-Linan M, Blount M, Yeo GS et al. 2007 PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genetics 27 e64

Moore JD, Caufield WV & Shaw WAQuantitation and standardization of lipid internal standards for mass spectroscopyAH Brown Lipodomics and Bioactive Lipids: Mass Spectrometry Based Lipid Analysis , Methods in Enzymology vol 4322007San Diego:Academic Press:351–367.[CrossRef][Web of Science][Medline]

Murph M, Tanaka T, Pang J, Felix E, Liu S, Trost R, Godwin AK, Newman R & Mills GLiquid chromatography mass spectrometry for quantifying plasma lysophospholipids: potential biomarkers for cancer diagnosisAH Brown Lipodomics and Bioactive Lipids: Specialized Analytical Methods and Lipids in Disease , Methods in Enzymology vol 4332007San Diego:Academic Press:1–25.[CrossRef][Web of Science][Medline]

Oresic M, Hänninen V & Vidal-Puig A 2008 Lipidomics: a new window to biomedical frontiers. Trends in Biotechnology 26 647–652.[CrossRef][Web of Science][Medline]

Schmitz G, Liebisch G & Langmann T 2006 Lipidomic strategies to study structural and functional defects of ABC-transporters in cellular lipid trafficking. FEBS Letters 580 5597–5610.[CrossRef][Web of Science][Medline]

Schwudke D, Oegema J, Burton L, Entchev E, Hannich JT, Ejsing CS, Kurzchalia T & Shevchenko A 2006 Lipid profiling by multiple precursor and neutral loss scanning driven by the data-dependent acquisition. Analytical Chemistry 78 585–595.[Medline]

Seppänen-Laakso T, Laakso I, Vanhanen H, Kiviranta K, Lehtimäki T & Hiltunen R 2001 Major human plasma lipid classes determined by quantitative high-performance liquid chromatography, their variation and associations with phospholipid fatty acids. Journal of Chromatography. B 754 437–445.[CrossRef]

Seppänen-Laakso T, Laakso I & Hiltunen R 2002 Analysis of fatty acids by gas chromatography, and its relevance to research on health and nutrition. Analytica Chimica Acta 465 39–64.[CrossRef][Web of Science]

Sommer U, Herscovitz H, Welty FK & Costello CE 2006 LC-MS based method for the qualitative and quantitative analysis of complex lipid mixtures. Journal of Lipid Research 47 804–814.[Abstract/Free Full Text]

Taguchi R, Houjou T, Nakanishi H, Yamazaki T, Ishida M, Imagawa M & Shimizu T 2005 Focused lipidomics by tandem mass spectrometry. Journal of Chromatography. B 823 26–36.[CrossRef]

von Thiele OW Lipide, Isoprenoide mit Steroiden ,1979Stuttgart:Georg Thieme Verlag:

Unger RH 2002 Lipotoxic diseases. Annual Review of Medicine 53 319–336.[CrossRef][Web of Science][Medline]

Wang D & DuBois RNMeasurement of eicosanoids in cancer tissueAH Brown Lipodomics and Bioactive Lipids: Specialized Analytical Methods and Lipids in Disease , Methods in Enzymology vol 4332007San Diego:Academic Press:27–50.[CrossRef][Web of Science][Medline]

Want EJ, Cravatt BF & Siuzdak G 2005 The expanding role of mass spectrometry in metabolite profiling and characterization. Chembiochem 6 1941–1951.[CrossRef][Web of Science][Medline]

Watson AD 2006 A global approach to lipid analysis in biological systems. Journal of Lipid Research 47 2101–2111.[Abstract/Free Full Text]

Yetukuri L, Katajamaa M, Medina-Gomez G, Seppänen-Laakso T, Vidal-Puig A & Oresic M 2007 Bioinformatics strategies for lipidomics analysis: characterization of obesity related hepatic steatosis. BMC Systems Biology 1 12[CrossRef][Medline]

Yetukuri L, Ekroos K, Vidal-Puig A & Oresic M 2008 Informatics and computational strategies for the study of lipids. Molecular BioSystems 4 121–127.[CrossRef][Web of Science][Medline]

Zemski Berry KA & Murphy RC 2005 Free radical oxidation of plasmalogen glycerophosphocholine containing esterified docosahexaenoic acid: structure determination by mass spectrometry. Antioxidants and Redox Signaling 7 157–169.[CrossRef][Web of Science][Medline]

Received in final form 24 November 2008
Accepted 5 December 2008
Made available online as an Accepted Preprint 5 December 2008





This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
JME-08-0150v1
42/3/185    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seppänen-Laakso, T.
Right arrow Articles by Oresic, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seppänen-Laakso, T.
Right arrow Articles by Oresic, M.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS